News for OMCL Stock
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
Omnicell Announces New Products for Perioperative and Clinic Settings
Omnicell Opens New Innovation Lab in Austin, Texas
Omnicell Announces First Quarter 2025 Results
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Omnicell Announces Chief Financial Officer Transition
Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Omnicell Announces OmniSphere
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes
Omnicell Announces Third Quarter 2024 Results
Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024
Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer
Omnicell Announces Central Med Automation Service
Omnicell to Present at the 2024 Wells Fargo Healthcare Conference
EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
Omnicell Announces Second Quarter 2024 Results
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
Omnicell to Present at the BofA Securities 2024 Health Care Conference
Omnicell Announces First Quarter 2024 Results
Omnicell Announces XT Amplify
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
Omnicell to Present at the 2023 Wells Fargo Healthcare Conference
Omnicell Announces Second Quarter 2023 Results
Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023
Omnicell Appoints Bobby Ghoshal to Board of Directors
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO
Omnicell Announces Leadership and Organizational Changes
Omnicell Appoints Nchacha E. Etta as Executive Vice President and Chief Financial Officer
Omnicell to Present at the BofA Securities 2023 Healthcare Conference
Omnicell Announces First Quarter 2023 Results
Long Island University and Omnicell Launch Center for Innovative Medication Management
Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023
Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results
CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
Omnicell Announces Financial Results for Third Quarter 2022
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
Omnicell to Present at the 2022 Wells Fargo Healthcare Conference
Omnicell to Host Investor Day on September 20, 2022
Omnicell Announces Financial Results for Second Quarter 2022
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
Omnicell Announces Financial Results for First Quarter 2022
Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
Omnicell Unveils Innovative IVX Station Robotic Compounding Technology in Winter 2022 Release
Omnicell Announces Changes to Its Board of Directors
UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes
Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results
Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022
Omnicell Acquires MarkeTouch Media
Omnicell Completes Acquisition of ReCept
Omnicell to Acquire ReCept
Omnicell to Present at Upcoming Investor Conferences
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals
Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
Omnicell Announces Financial Results for Third Quarter 2021
Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021
FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During Medicare Open Enrollment
Omnicell Completes Acquisition of FDS Amplicare
Omnicell Grows International Footprint with Opening of Omnicell India Software Development Center
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release
Spartanburg Regional Healthcare System Partners with Omnicell to Drive Improved Clinical and Operational Outcomes
Omnicell Announces Financial Results for Second Quarter 2021
Omnicell to Acquire FDS Amplicare
Omnicell Appoints Edward Bousa to Board of Directors
Omnicell to Release Second Quarter 2021 Financial Results on July 29, 2021
Chartwell Enhances IV Preparations with Omnicell® IVX Workflow
Scripps Health Selects Omnicell Medication Management Solutions to Help Improve Clinical and Operational Efficiency
Omnicell Announces Financial Results for First Quarter 2021
EnlivenHealth Partners With Twilio to Accelerate Launch of Transformative Patient Communications Solutions
Aultman Health Foundation to Enhance Medication Management with Omnicell’s Central Pharmacy Dispensing Service
Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021
The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
Omnicell Appoints Christine Mellon as Chief People Officer
Omnicell to Present at Upcoming Investor Conferences
Omnicell Reports Fiscal Year and Fourth Quarter 2020 Results
WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, and Support Better Patient Care
Omnicell Announces Preliminary Fiscal Year 2020 Financial Results
Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges
Omnicell to Partner with Guy’s and St Thomas’ NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems Across the South East London NHS Integrated Care System
Owensboro Health to Deploy Omnicell’s Technology-Enabled Services to Improve Safety and Efficiency in Medication Management
Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference
New National Survey Finds the Majority of Retail Pharmacies and Health Plans Are Concerned About People Actually Taking the COVID-19 Vaccine Once It’s Available
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020
Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network
Omnicell to Present at Upcoming Investor Conferences
Omnicell Reports Third Quarter 2020 Results
Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Clinical and Operational Outcomes and Streamline Medication Management
Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispensing Service to Enhance Medication Safety and Dispensing Efficiency
Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell to Release Third Quarter 2020 Earnings Results on October 27, 2020
Back to Sitemap